Health Condition 1: null- All subjects implanted with Medtronic Cardiac devices with the Cardiac Compass® and OptiVol® feature can be evaluated for the study.
Conditions
Interventions
None listed
Sponsors
Medtronic Inc
India Medtronic Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subject must be greater than 18 years of age. 2.Subject must have an implanted Medtronic CRHF device (with the Optivol® and Cardiac Compass® diagnostics) for at least 1 year. 3.Subjects between 18 years and 62 years of age must have at least 1 clinical event ,such as any major medication change, IV drug therapy, hospitalization, outside home-treatment or any similar event in the past 1 year from the date of enrollment which required a Pharmacologic intervention, associated with any of the following comorbid conditions a) Heart failure b) Chronic Obstructive Pulmonary Disease (COPD) c) Renal deficiency d) Atrial fibrillation e) Diabetes 4. Subjects who are currently hospitalized with an Index clinical event can also be enrolled. 5. If the subject is over 62 years of age then subject can be enrolled in the study without any pre-condition of a clinical event associated with a comorbid condition.
Exclusion criteria
Exclusion criteria: Subject is unwilling or unable to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlate the device measured diagnostics parameters to any clinical event in subjects which lead to a major medication change, IV drug therapy, hospitalization, outside home treatment or any similar event. This will help outline the diagnostic changes seen in such subjects prior to acute clinical events.Timepoint: Study does not have any follow up visit and only looks retrospective events of patients and this data will be evaluated at the end of six months on the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: NA | — |
Countries
India
Contacts
Public ContactVinay Rajan
India Medtronic Pvt Ltd
Outcome results
None listed